Navigating regulation in the healthcare industry can be extraordinarily complex. Our attorneys have vast institutional knowledge and experience executing transactions in this industry and its distinct subsectors. With extensive involvement on both buy and sell-side transactions, Kirkland attorneys are able to analyze matters from all perspectives and guide clients through the intricate issues unique to the healthcare industry.
Kirkland's healthcare regulatory team has deep experience advising clients on a broad range of issues including federal and multi-state matters, structuring, the Federal Anti-Kickback Statute, state anti-kickback laws, the Federal False Claims Act, fraud and abuse related regulatory issues with additional experience in federal and state licensure, corporate practice of medicine and professionals doctrine, compliance, enrollment and reimbursement matters.
In addition to Kirkland’s internal capabilities, our long-standing, strategic relationships with specialty health care regulatory counsel allow us to select the right partnership based on specific deal characteristics and unique industry niche, and to provide seamless, best-in-class, cost-efficient service on health care M&A and regulatory issues.
65+ Healthcare & Life Sciences Transactions
Healthcare & Pharma Law Firm of the Year
The Deal, 2019
$235B Total Value of Healthcare & Life Sciences Transactions